Amneal Pharmaceuticals, Inc.
Pharmaceutical Preparations
- Revenue, 2025
- $3.02B
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Institutional holders
- 308 at 30 Jun 2026 (317 the quarter before)
- SEC number
- 1723128
- LEI
- 549300VV176ZO5WQHZ61
Source: SEC EDGAR filings and company facts, SEC Form 13F; checked 27 Oct 2026
Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company in pharmaceutical industry, headquartered in Hayward.
Source: Wikidata
Source: SEC EDGAR
A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.